Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference14 articles.
1. Zuehlke RL. Erythematous eruption of the palms and soles associated with mitotane therapy. Dermatologica. 1974;148:90–2.
2. Lipworth AD, Robert C, Zhu AX. Hand–foot syndrome (hand–foot skin reaction, palmar–plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology. 2009;77:257–71.
3. Abushullaih S, Saad ED, Munsell M, Hoff PM. Incidence and severity of hand–foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience. Cancer Investig. 2002;20:3–10.
4. Heo YS, Chang HM, Kim TW, Ryu MH, Ahn JH, Kim SB, et al. Hand–foot syndrome in patients treated with capecitabine-containing combination chemotherapy. J Clin Pharmacol. 2004;44:1166–72.
5. Marse H, Van Cutsem E, Grothey A, Valverde S. Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs. 2004;8(Suppl 1):S16-30.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献